COVID 19 Vaccinations – Not the Ultimate Solution - LSW Report by S G B Rao, Publisher & Managing Partner, LSW LifeScienceworld
India started its national vaccination programme against the Covid 19 on 16th January 2021. Under the drive’s first phase, only health care workers and frontline workers were vaccinated till the end of February. Phase two of the drive included people over 60 years of age and those aged 45 and above with specified co-morbid conditions. […]
Digital Health Technology - The Next Big Thing in Healthcare
Digital Technology has become the future of Health care not only in developed countries of the World but also in the developing countries for the simple reason, that Digital health has the potential to prevent disease and lower healthcare costs, while helping patients monitor and manage chronic conditions. It can also tailor medicine for individual […]
Artificial Intelligence – How is it relevant in the field of HealthCare
Artificial intelligence is defined by John McCarthy as the ability of a computer program or a machine to think and learn. It is also a field of study which tries to make computers "smart". They work on their own without being encoded with commands. Artificial intelligence in the field of Medical Science mainly uses computer […]
Real World Data (RWD) and Real World Evidence (RWE) in a Healthcare
Real-world data (RWD) is data relating to patient health status and/or the delivery of health care routinely collected from a variety of sources. Real-world evidence (RWE) is the clinical evidence regarding the usage and potential benefits or risks of a medical product derived from the analysis of RWD. The Real World evidence is a derivative […]
Evolution of doing Clinical Trials after pandemic
LSW is in its 10th year of existence. The inaugural issue featured an interview with Late Padmashri Prof. (Dr) Ranjit Roy Chaudhury, who was our well-wisher and the first Advisory Board Member. His guidance and suggestions on editorial and on other fronts helped us in our endeavour and to play an important role by supporting […]
Multinational Pharmaceutical Companies in India: Navigating Regulatory Challenges
Multinational pharmaceutical companies operating in India currently face several regulatory challenges stemming from the country’s evolving healthcare policy landscape, pricing regulations, intellectual property regime, and compliance expectations. The following are the core issues: Price Controls by NPPA Quoting source Businessdrugcontrol.org, as of March 25, 2025, ceiling prices have been fixed for 928 scheduled formulations, with […]
